— Receives New Designation for Treatment of Platelet-Activating Anti-Platelet Factor 4 (PF4) Disorders — Complements FDA Orphan Drug Designation and Fast Track Designation for VLX-1005 Source: Veralox Frederick, MD, Aug. 14, 2024 – Veralox Therapeutics, a clinical-stage biotechnology company developing first-in-class therapies targeting the 12-lipoxygenase (12-LOX) pathway, announced that the European Medicines Agency (EMA) has granted Orphan … Read more
WDAdmin
By Anna Eyler In a rapidly evolving business landscape, startups that don’t consider implementing emerging technologies like artificial intelligence (AI) and robotics into their operations are at risk of being left behind. Leveraging these tools allows employees to spend more time and energy on strategic tasks that require high-level critical thinking. By integrating AI-driven algorithms … Read more
By Anna Eyler Circular business practices revolutionize industries, mitigate environmental impact, minimize waste generation, achieve cost reductions, and drive sustainable innovation for a brighter future. In a circular economy, materials and products are utilized for their maximum lifespan. Cutting-edge innovations from companies like InventWood and Quantum Loophole are shining examples of how local ingenuity will … Read more

